Trade Mark Journal No.2026/045 6 November 2026

UK00004462680 20 October 2026 (5,42)

BALSAM BIO

International priority date claimed: 21 April 2026 (United States of America) (99777475)

Class 5: Pharmaceutical preparations; pharmaceutical preparations for the treatment of aging for therapeutic purposes; pharmaceutical preparations for the treatment of immune decline for therapeutic purposes; pharmaceutical preparations for the treatment of hematopoietic stem cells (HSCs); pharmaceutical preparations for the treatment of depletion of myeloid-biased hematopoietic stem cells (HSCs); pharmaceutical preparations for the treatment of clonally expanded mutant hematopoietic stem cells (HSCs).
Class 42: Medical and scientific research; medical and scientific research in the fields of hematopoietic stem cells (HSCs), aging, and immune decline.

Balsam Bio, Inc.

Representative: Abion UK Limited